Cycle Pharmaceuticals completes acquisition of Banner Life Sciences, LLC to expand MS product portfolio
Cycle Pharmaceuticals completes acquisition of Banner Life Sciences, LLC to expand MS product portfolio
01/13/25, 10:22 AM
Location
cambridge
high pointIndustry
pharmaceutical
biotechnology
health care
pharmaceutical
biotechnology
health care
Cycle Pharmaceuticals, Inc. has successfully completed the acquisition of Banner Life Sciences, LLC including its BAFIERTAM® product for the treatment of relapsing forms of multiple sclerosis (MS), in adults, approved by the US Food and Drug Administration (FDA). With this acquisition, Cycle will broaden its MS product portfolio and strengthen its commitment to providing high-quality medicines and support to patients.
Company Info
Location
Cambridge, England, United Kingdom
Company info
Cycle Pharmaceuticals was founded in 2012 with the sole aim of delivering drug treatments and product support to the underserved rare disease patient community. Cycle focuses on rare metabolic, immunological, and neurological genetic conditions. Within neurological conditions, we focus on multiple sclerosis. Cycle is headquartered in Cambridge, UK and has offices in Boston, Massachusetts.